A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Acalabrutinib D4 | CAS 2699608-18-7 - Request Quote

Picture of Acalabrutinib D4

Acalabrutinib D4

SZ CAT No:SZ-A078D01
CAS No
2699608-18-7
Mol.F.
C26H19D4N7O2
Mol.Wt.
469.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Acalabrutinib D4 is chemically (S)-4-(8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl-d4)benzamide. Acalabrutinib D4 is supplied with detailed characterization data compliant with regulatory guideline. Acalabrutinib D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acalabrutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2699608-18-7

Purchase 2699608-18-7

Order 2699608-18-7

Enquire 2699608-18-7

price of 2699608-18-7

2699608-18-7 Supplier

2699608-18-7 Manufacturer

2699608-18-7 Exporter

buy high quality Acalabrutinib D4

Purchase Acalabrutinib D4

Acalabrutinib D4 suppliers

Acalabrutinib D4 manufacturers

Acalabrutinib D4 price

Order Acalabrutinib D4

Enquire Acalabrutinib D4

Acalabrutinib D4 cost

Acalabrutinib D4 Supplier

Acalabrutinib D4 Distributor

Acalabrutinib D4 for Method Validation

Acalabrutinib Reference Standard

Acalabrutinib D4 for ANDA Filing

Acalabrutinib D4 for Forced Degradation Studies

Acalabrutinib D4 Identification Standards

Acalabrutinib D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,